Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Social Media | 2 | 2023 | 120 | 0.860 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 3 | 2022 | 51 | 0.790 |
Why?
|
| Hypertension | 5 | 2024 | 1349 | 0.730 |
Why?
|
| Polyuria | 1 | 2022 | 9 | 0.720 |
Why?
|
| Polydipsia | 1 | 2022 | 4 | 0.720 |
Why?
|
| Nephrology | 1 | 2023 | 159 | 0.710 |
Why?
|
| Blood Component Removal | 1 | 2021 | 35 | 0.670 |
Why?
|
| Renal Dialysis | 4 | 2023 | 947 | 0.650 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2021 | 109 | 0.600 |
Why?
|
| Medication Systems | 1 | 2019 | 7 | 0.590 |
Why?
|
| Kidney Failure, Chronic | 4 | 2020 | 932 | 0.580 |
Why?
|
| Genu Valgum | 1 | 2018 | 3 | 0.580 |
Why?
|
| Electronic Prescribing | 1 | 2019 | 30 | 0.580 |
Why?
|
| Familial Hypophosphatemic Rickets | 1 | 2018 | 7 | 0.570 |
Why?
|
| Hypercalciuria | 1 | 2018 | 9 | 0.570 |
Why?
|
| Vascular Stiffness | 1 | 2019 | 76 | 0.550 |
Why?
|
| Arterial Pressure | 1 | 2019 | 130 | 0.550 |
Why?
|
| Medication Errors | 1 | 2019 | 192 | 0.500 |
Why?
|
| Kidney Diseases | 1 | 2021 | 472 | 0.500 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2023 | 848 | 0.440 |
Why?
|
| Pediatrics | 1 | 2023 | 1242 | 0.410 |
Why?
|
| Plasma Exchange | 2 | 2021 | 86 | 0.310 |
Why?
|
| Complement Inactivating Agents | 1 | 2026 | 14 | 0.240 |
Why?
|
| Atypical Hemolytic Uremic Syndrome | 1 | 2026 | 13 | 0.240 |
Why?
|
| Child | 11 | 2026 | 26181 | 0.230 |
Why?
|
| Pruritus | 1 | 2023 | 51 | 0.190 |
Why?
|
| Education, Distance | 1 | 2023 | 69 | 0.190 |
Why?
|
| Humans | 17 | 2026 | 130154 | 0.180 |
Why?
|
| Peritoneal Dialysis | 2 | 2020 | 133 | 0.170 |
Why?
|
| Hand | 1 | 2022 | 93 | 0.170 |
Why?
|
| Dyspnea | 1 | 2022 | 159 | 0.170 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2026 | 565 | 0.170 |
Why?
|
| White Coat Hypertension | 1 | 2021 | 10 | 0.170 |
Why?
|
| Adolescent | 8 | 2026 | 20802 | 0.160 |
Why?
|
| Hydrothorax | 1 | 2020 | 10 | 0.160 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2020 | 22 | 0.160 |
Why?
|
| Calcimimetic Agents | 1 | 2019 | 5 | 0.160 |
Why?
|
| Education, Medical | 1 | 2023 | 290 | 0.150 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2019 | 17 | 0.150 |
Why?
|
| Male | 10 | 2026 | 64397 | 0.150 |
Why?
|
| Pulse Wave Analysis | 1 | 2019 | 48 | 0.140 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2018 | 3 | 0.140 |
Why?
|
| Curriculum | 1 | 2023 | 793 | 0.140 |
Why?
|
| Pharmacists | 1 | 2019 | 103 | 0.130 |
Why?
|
| Arteries | 1 | 2019 | 209 | 0.130 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 777 | 0.120 |
Why?
|
| Blood Volume | 1 | 2016 | 73 | 0.120 |
Why?
|
| Registries | 1 | 2021 | 1610 | 0.100 |
Why?
|
| Quality of Life | 1 | 2023 | 2072 | 0.100 |
Why?
|
| Female | 9 | 2026 | 70285 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1872 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2289 | 0.090 |
Why?
|
| Blood Pressure | 3 | 2024 | 1340 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3781 | 0.080 |
Why?
|
| Prognosis | 1 | 2018 | 4848 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 4032 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3407 | 0.060 |
Why?
|
| Young Adult | 2 | 2019 | 9987 | 0.060 |
Why?
|
| Complement System Proteins | 1 | 2026 | 58 | 0.060 |
Why?
|
| Remission Induction | 1 | 2026 | 306 | 0.060 |
Why?
|
| Mutation | 1 | 2018 | 6070 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 118 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 2094 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2026 | 15009 | 0.050 |
Why?
|
| Drug Monitoring | 1 | 2026 | 287 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2024 | 206 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2024 | 5042 | 0.040 |
Why?
|
| Adult | 2 | 2021 | 31042 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2024 | 413 | 0.040 |
Why?
|
| Fatigue | 1 | 2022 | 191 | 0.040 |
Why?
|
| Radiography | 1 | 2022 | 740 | 0.040 |
Why?
|
| Hypocalcemia | 1 | 2020 | 36 | 0.040 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 49 | 0.040 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2020 | 51 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2026 | 17554 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1440 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2020 | 226 | 0.030 |
Why?
|
| Infant | 2 | 2026 | 13276 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 423 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2016 | 185 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2058 | 0.030 |
Why?
|
| Kidney | 1 | 2020 | 1279 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2016 | 534 | 0.030 |
Why?
|
| Heart Rate | 1 | 2016 | 573 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2026 | 12843 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 10953 | 0.010 |
Why?
|